Lifecore Biomedical
LFCR
LFCR
98 hedge funds and large institutions have $287M invested in Lifecore Biomedical in 2021 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 30 increasing their positions, 38 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
1.15% more ownership
Funds ownership: 86.68% → 87.83% (+1.1%)
21% less repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 38
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $116K
Holders
98
Holding in Top 10
5
Calls
–
Puts
$116K
Top Buyers
| 1 | +$4.88M | |
| 2 | +$4.11M | |
| 3 | +$3.07M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$1.97M |
| 5 |
TAM
Tocqueville Asset Management
New York
|
+$1.46M |
Top Sellers
| 1 | -$2.74M | |
| 2 | -$2.52M | |
| 3 | -$2.02M | |
| 4 |
BlackRock
New York
|
-$1.84M |
| 5 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
-$1.02M |